Literature DB >> 22215850

Drug approvals 2011: focus on companion diagnostics.

Merrill Goozner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22215850     DOI： 10.1093/jnci/djr552

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim Geisinger; Yasushi Yatabe; Yuichi Ishikawa; Ignacio Wistuba; Douglas B Flieder; Wilbur Franklin; Adi Gazdar; Philip S Hasleton; Douglas W Henderson; Keith M Kerr; Iver Petersen; Victor Roggli; Erik Thunnissen; Ming Tsao
Journal:  Arch Pathol Lab Med       Date:  2012-09-12       Impact factor: 5.534

2.  Absence of BRAF exon 15 mutations in multiple myeloma and Waldenström's macroglobulinemia questions its validity as a therapeutic target in plasma cell neoplasias.

Authors:  Eleftheria Hatzimichael; Samuel Murray; Evangelos Briasoulis
Journal:  Am J Blood Res       Date:  2013-05-05

Review 3.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

4.  Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development.

Authors:  Xuemin Gu; Nan Chen; Caimiao Wei; Suyu Liu; Vassiliki A Papadimitrakopoulou; Roy S Herbst; J Jack Lee
Journal:  Stat Biosci       Date:  2014-12-04

Review 5.  Incorporation of prognostic and predictive factors into glioma clinical trials.

Authors:  Derek R Johnson; Evanthia Galanis
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

6.  A framework for genomic biomarker actionability and its use in clinical decision making.

Authors:  Smruti J Vidwans; Michelle L Turski; Filip Janku; Ignacio Garrido-Laguna; Javier Munoz; Richard Schwab; Vivek Subbiah; Jordi Rodon; Razelle Kurzrock
Journal:  Oncoscience       Date:  2014-10-22

7.  Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.

Authors:  Anna Szlachcic; Malgorzata Zakrzewska; Michal Lobocki; Piotr Jakimowicz; Jacek Otlewski
Journal:  Drug Des Devel Ther       Date:  2016-08-09       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.